天目药业
(600671)
| 流通市值：24.72亿 | | | 总市值：24.72亿 |
| 流通股本：1.22亿 | | | 总股本：1.22亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 99,354,720.89 | 44,388,576.68 | 211,753,756.64 | 158,940,412.66 |
| 营业收入 | 99,354,720.89 | 44,388,576.68 | 211,753,756.64 | 158,940,412.66 |
| 二、营业总成本 | 93,084,469.7 | 39,629,817.55 | 202,114,934.39 | 149,050,601.43 |
| 营业成本 | 49,300,638.16 | 20,083,404.99 | 110,612,906.03 | 85,227,696.11 |
| 税金及附加 | 1,134,424.24 | 558,010.84 | 2,561,943.09 | 1,850,426.12 |
| 销售费用 | 9,185,882.35 | 3,473,662.92 | 13,454,395.14 | 10,165,110.27 |
| 管理费用 | 30,101,278.45 | 13,947,158.25 | 68,396,562.41 | 46,836,705.48 |
| 财务费用 | 3,362,246.5 | 1,567,580.55 | 7,089,127.72 | 4,970,663.45 |
| 其中:利息费用 | 3,376,624.56 | 1,559,259.55 | 7,198,209.47 | 5,051,561.39 |
| 其中:利息收入 | 29,773.54 | 300.53 | 138,604.59 | 82,941.43 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -5,590.28 | - | 1,708,564.94 | 3,993.35 |
| 资产处置收益 | - | - | 366,510.98 | 299,864.55 |
| 资产减值损失(新) | -60,200.18 | - | -1,657,052.82 | -604,734.79 |
| 信用减值损失(新) | -1,945,151.24 | -408,923.29 | -2,102,766.51 | -2,726,517.05 |
| 其他收益 | 276,184.46 | 177,379.02 | 438,647.84 | 291,106.67 |
| 四、营业利润 | 4,535,493.95 | 4,527,214.86 | 8,392,726.68 | 7,153,523.96 |
| 加:营业外收入 | 3,805,384.37 | 1,451,288.21 | 7,952,584.42 | 6,500,620.8 |
| 减:营业外支出 | 56,644.76 | 44,173.64 | 6,120,919.78 | 3,652,956.02 |
| 五、利润总额 | 8,284,233.56 | 5,934,329.43 | 10,224,391.32 | 10,001,188.74 |
| 减:所得税费用 | 3,342,882.99 | 2,844,339.73 | 3,021,446.15 | 2,493,114.95 |
| 六、净利润 | 4,941,350.57 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 4,941,350.57 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 6,302,215.9 | 3,816,104.36 | 17,622,617.59 | 14,208,796.6 |
| 少数股东损益 | -1,360,865.33 | -726,114.66 | -10,419,672.42 | -6,700,722.81 |
| 扣除非经常损益后的净利润 | 2,320,945.14 | 2,265,284.42 | 13,470,505.09 | 10,882,970.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.05 | 0.03 | 0.14 | 0.12 |
| (二)稀释每股收益 | 0.05 | 0.03 | 0.14 | 0.12 |
| 九、综合收益总额 | 4,941,350.57 | 3,089,989.7 | 7,202,945.17 | 7,508,073.79 |
| 归属于母公司股东的综合收益总额 | 6,302,215.9 | 3,816,104.36 | 17,622,617.59 | 14,208,796.6 |
| 归属于少数股东的综合收益总额 | -1,360,865.33 | -726,114.66 | -10,419,672.42 | -6,700,722.81 |
| 公告日期 | 2026-08-28 | 2026-04-30 | 2026-04-18 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |